IAPP and type 2 diabetes mellitus: The depressant effects of Aβ (1-42) and human amylin on hippocampal long-term potentiation (LTP) were blocked by the application of AC253, an antagonist developed for the treatment of T2DM, in the APP transgenic mouse model [186].